Green tea extract and its major polyphenol (-)-epigallocatechin gallate improve muscle function in a mouse model for Duchenne muscular dystrophy

American Journal of Physiology - Cell Physiology

Volumn 290, Issue 2, 2006, Pages

  Dorchies, Olivier M ^a   Wagner, Stéphanie ^a   Vuadens, Ophélie ^a   Waldhauser, Katri ^a   Buetler, Timo M ^a   Kucera, Pavel ^b   Ruegg, Urs T ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Dystrophic mdx5cv mouse; Muscle histology; Muscle mechanical properties; Muscular disorders; Pharmacotherapy

Indexed keywords

ANTIOXIDANT; EPIGALLOCATECHIN GALLATE; GREEN TEA EXTRACT; PENTOXIFYLLINE; POLYPHENOL DERIVATIVE; CATECHIN; DRUG DERIVATIVE; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; SCAVENGER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFECT; DUCHENNE MUSCULAR DYSTROPHY; EXTENSOR DIGITORUM LONGUS MUSCLE; FOOD INTAKE; HISTOLOGY; MOUSE; MUSCLE BIOPSY; MUSCLE FATIGUE; MUSCLE FORCE; MUSCLE FUNCTION; MUSCLE ISOMETRIC CONTRACTION; MUSCLE NECROSIS; MUSCLE RELAXATION; MUSCLE TETANIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL; TRICEPS SURAE MUSCLE; ANIMAL; C57BL MOUSE; CHEMISTRY; CYTOLOGY; DIET; DISEASE MODEL; HUMAN; METABOLISM; MUSCLE CONTRACTION; PATHOLOGY; PHYSIOLOGY; PHYTOTHERAPY; SKELETAL MUSCLE; TEA; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

ANIMALIA;

ANIMALS; ANTIOXIDANTS; CAMELLIA SINENSIS; CATECHIN; DIET; DISEASE MODELS, ANIMAL; FREE RADICAL SCAVENGERS; HUMANS; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MUSCLE CONTRACTION; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; PENTOXIFYLLINE; PHYTOTHERAPY; PLANT EXTRACTS; PLANT PREPARATIONS;

EID: 33644854044     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00425.2005     Document Type: Article

References (49)

1. Agbulut O, Li Z, Mouly V, and Butler-Browne GS. Analysis of skeletal and cardiac muscle from desmin knock-out and normal mice by high resolution separation of myosin heavy-chain isoforms. Biol Cell 88: 131-135, 1996.
2. Andrade FH, Reid MB, Allen DG, and Westerblad H. Effect of hydrogen peroxide and dithiothreitol on contractile function of single skeletal muscle fibres from the mouse. J Physiol 509: 565-575, 1998.
3. Aneja R, Hake PW, Burroughs TJ, Denenberg AG, Wong HR, and Zingarelli B. Epigallocatechin, a green tea polyphenol, attenuates myocardial ischemia reperfusion injury in rats. Mol Med 10: 55-62, 2004.
4. Arakawa H, Maeda M, Okubo S, and Shimamura T. Role of hydrogen peroxide in bactericidal action of catechin. Biol Pharm Bull 27: 277-281, 2004.
5. Ashida H, Furuyashiki T, Nagayasu H, Bessho H, Sakakibara H, Hashimoto T, and Kanazawa K. Anti-obesity actions of green tea: possible involvements in modulation of the glucose uptake system and suppression of the adipogenesis-related transcription factors. Biofactors 22: 135-140, 2004.
6. Blake DJ, Weir A, Newey SE, and Davies KE. Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol Rev 82: 291-329, 2002.
7. Brown MD. Green tea (Camellia sinensis) extract and its possible role in the prevention of cancer. Altern Med Rev 4: 360-370, 1999.
8. Buetler TM, Renard M, Offord EA, Schneider H, and Ruegg UT. Green tea extract decreases muscle necrosis in mdx mice and protects against reactive oxygen species. Am J Clin Nutr 75: 749-753, 2002.
9. Chow HH, Cai Y, Alberts DS, Hakim I, Dorr R, Shahi F, Crowell JA, Yang CS, and Hara Y. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E. Cancer Epidemiol Biomarkers Prev 10: 53-58, 2001.
10. Das M, Vedasiromoni JR, Chauhan SP, and Ganguly DK. Effect of green tea (Camellia sinensis) extract on the rat diaphragm. J Ethnopharmacol 57: 197-201, 1997.
11. De Luca A, Nico B, Liantonio A, Didonna MP, Fraysse B, Pierno S, Burdi R, Mangieri D, Rolland JF, Camerino C, Zallone A, Confalonieri P, Andreetta F, Arnoldi E, Courdier-Fruh I, Magyar JP, Frigeri A, Pisoni M, Svelto M, and Conte Camerino D. A multidisciplinary evaluation of the effectiveness of cyclosporine A in dystrophic mdx mice. Am J Pathol 166: 477-489, 2005.
12. Dona M, Dell'Aica I, Calabrese F, Benelli R, Morini M, Albini A, and Garbisa S. Neutrophil restraint by green tea: inhibition of inflammation, associated angiogenesis, and pulmonary fibrosis. J Immunol 170: 4335-4341, 2003.
13. Fassina G, Buffa A, Benelli R, Varnier OE, Noonan DM, and Albini A. Polyphenolic antioxidant (-)-epigallocatechin-3-gallate from green tea as a candidate anti-HIV agent. AIDS 16: 939-941, 2002.
14. Gailly P. New aspects of calcium signaling in skeletal muscle cells: implications in Duchenne muscular dystrophy. Biochim Biophys Acta 1600: 38-44, 2002.
15. Granchelli JA, Pollina C, and Hudecki MS. Pre-clinical screening of drugs using the mdx mouse. Neuromuscul Disord 10: 235-239, 2000.
16. Higdon JV and Frei B. Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit Rev Food Sci Nutr 43: 89-143, 2003.
17. Hong JT, Ryu SR, Kim HJ, Lee JK, Lee SH, Kim DB, Yun YP, Ryu JH, Lee BM, and Kim PY. Neuroprotective effect of green tea extract in experimental ischemia-reperfusion brain injury. Brain Res Bull 53: 743-749, 2000.
18. Im WB, Phelps SF, Copen EH, Adams EG, Slightom JL, and Chamberlain JS. Differential expression of dystrophin isoforms in strains of mdx mice with different mutations. Hum Mol Genet 5: 1149-1153, 1996.
19. Kang WS, Chung KH, Chung JH, Lee JY, Park JB, Zhang YH, Yoo HS, and Yun YP. Antiplatelet activity of green tea catechins is mediated by inhibition of cytoplasmic calcium increase. J Cardiovasc Pharmacol 38: 875-884, 2001.
20. Khurana TS and Davies KE. Pharmacological strategies for muscular dystrophy. Nat Rev Drug Discov 2: 379-390, 2003.
21. Lambert JD, Lee MJ, Lu H, Meng X, Hong JJ, Seril DN, Sturgill MG, and Yang CS. Epigallocatechin-3-gallate is absorbed but extensively glucuronidated following oral administration to mice. J Nutr 133: 4172-4177, 2003.
22. Leijendekker WJ, Passaquin AC, Metzinger L, and Ruegg UT. Regulation of cytosolic calcium in skeletal muscle cells of the mdx mouse under conditions of stress. Br J Pharmacol 118: 611-616, 1996.
23. Louis M, Lebacq J, Poortmans JR, Belpaire-Dethiou MC, Devogelaer JP, Van Hecke P, Goubel F, and Francaux M. Beneficial effects of creatine supplementation in dystrophic patients. Muscle Nerve 27: 604-610, 2003.
24. Metzinger L, Passaquin AC, Leijendekker WJ, Poindron P, and Ruegg UT. Modulation by prednisolone of calcium handling in skeletal muscle cells. Br J Pharmacol 116: 2811-2816, 1995.
25. Muntoni F, Fisher I, Morgan JE, and Abraham D. Steroids in Duchenne muscular dystrophy: from clinical trials to genomic research. Neuromuscul Disord 12, Suppl 1: S162-S165, 2002.
26. Murase T, Haramizu S, Shimotoyodome A, Nagasawa A, and Tokimitsu I. Green tea extract improves endurance capacity and increases muscle lipid oxidation in mice. Am J Physiol Regul Integr Comp Physiol 288: R708-R715, 2005.
27. Nakachi K, Eguchi H, and Imai K. Can teatime increase one's lifetime? Ageing Res Rev 2: 1-10, 2003.
28. Nakagawa T and Yokozawa T. Direct scavenging of nitric oxide and superoxide by green tea. Food Chem Toxicol 40: 1745-1750, 2002.
29. Nowak KJ and Davies KE. Duchenne muscular dystrophy and dystrophin: pathogenesis and opportunities for treatment: Third in Molecular Medicine Review Series. EMBO Rep 5: 872-876, 2004.
30. 2+ currents in bovine chromaffin cells by green tea polyphenol extracts. Neurochem Int 40: 131-137, 2002.
31. Passaquin AC, Renard M, Kay L, Challet C, Mokhtarian A, Wallimann T, and Ruegg UT. Creatine supplementation reduces skeletal muscle degeneration and enhances mitochondrial function in mdx mice. Neuromuscul Disord 12: 174-182, 2002.
32. Petrof BJ, Shrager JB, Stedman HH, Kelly AM, and Sweeney HL. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc Natl Acad Sci USA 90: 3710-3714, 1993.
33. Rando TA. Oxidative stress and the pathogenesis of muscular dystrophies. Am J Phys Med Rehabil 81: S175-186, 2002.
34. Riemersma RA, Rice-Evans CA, Tyrrell RM, Clifford MN, and Lean MEJ. Tea flavonoids and cardiovascular health. QJM 94: 277-282, 2001.
35. Ruegg UT, Nicolas-Metral V, Challet C, Bernard-Helary K, Dorchies OM, Wagner S, and Buetler TM. Pharmacological control of cellular calcium handling in dystrophic skeletal muscle. Neuromuscul Disord 12: S155-S161, 2002.
36. Sacco P, Jones DA, Dick JR, and Vrbova G. Contractile properties and susceptibility to exercise-induced damage of normal and mdx mouse tibialis anterior muscle. Clin Sci (Lond) 82: 227-236, 1992.
37. Saito M, Saito K, Kunisaki N, and Kimura S. Green tea polyphenols inhibit metalloproteinase activities in the skin, muscle, and blood of rainbow trout. J Agric Food Chem 50: 7169-7174, 2002.
38. Spencer MJ and Tidball JG. Do immune cells promote the pathology of dystrophin-deficient myopathies? Neuromuscul Disord 11: 556-564, 2001.
39. Squire S, Raymackers JM, Vandebrouck C, Potter A, Tinsley J, Fisher R, Gillis JM, and Davies KE. Prevention of pathology in mdx mice by expression of utrophin: analysis using an inducible transgenic expression system. Hum Mol Genet 11: 3333-3344, 2002.
40. St-Pierre SJG, Chakkalakal JV, Kolodziejczyk SM, Knudson JC, Jasmin BJ, and Megeney LA. Glucocorticoid treatment alleviates dystrophic myofiber pathology by activation of the calcineurin/NF-AT pathway. FASEB J 18: 1937-1939, 2004.
41. Suzuki M, Tabuchi M, Ikeda M, Umegaki K, and Tomita T. Protective effects of green tea catechins on cerebral ischemic damage. Med Sci Monit 10: BR166-BR174, 2004.
42. Tachibana H, Koga K, Fujimura Y, and Yamada K. A receptor for green tea polyphenol EGCG. Nat Struct Mol Biol 11: 380-381, 2004.
43. Tanabe Y, Esaki K, and Nomura T. Skeletal muscle pathology in X chromosome-linked muscular dystrophy (mdx) mouse. Acta Neuropathol (Berl) 69: 91-95, 1986.
44. Tidball J and Wehling-Henricks M. Evolving therapeutic strategies for Duchenne muscular dystrophy: targeting downstream events. Pediatr Res 56: 831-841, 2004.
45. Townsend PA, Scarabelli TM, Pasini E, Gitti G, Menegazzi M, Suzuki H, Knight RA, Latchman DS, and Stephanou A. Epigallocatechin-3-gallate inhibits STAT-1 activation and protects cardiac myocytes from ischemia/reperfusion- induced apoptosis. FASEB J 18: 1621-1623, 2004.
46. Wang HK. The therapeutic potential of flavonoids. Expert Opin Investig Drugs 9: 2103-2119, 2000.
47. Williams SN, Pickwell GV, and Quattrochi LC. A combination of tea (Camellia sinensis) catechins is required for optimal inhibition of induced CYP1A expression by green tea extract. J Agric Food Chem 51: 6627-6634, 2003.
48. Yeh CW, Chen WJ, Chiang CT, Lin-Shiau SY, and Lin JK. Suppression of fatty acid synthase in MCF-7 breast cancer cells by tea and tea polyphenols: a possible mechanism for their hypolipidemic effects. Pharmacogenomics J 3: 267-276, 2003.
49. Zhong Z, Froh M, Lehnert M, Schoonhoven R, Yang L, Lind H, Lemasters JJ, and Thurman RG. Polyphenols from Camellia sinensis attenuate experimental cholestasis-induced liver fibrosis in rats. Am J Physiol Gastrointest Liver Physiol 285: G1004-G1013, 2003.